4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021385
Options or other derivatives
- Sr. VP, Business Dev. acquired 83,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Luu Brendan Sr. VP, Business Dev. | 2023-11-22 | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…